ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2272

Physical Performance Contributes Only Marginally in Explaining Fatigue Variation in Persons with RA Moderately Affected By Their Disease

Ingrid Demmelmaier1, Susanne Pettersson1, Birgitta Nordgren1, Alyssa B. Dufour1,2 and Christina H. Opava1, 1Department of Neurobiology, Care Sciences and Society, Division of Physiotherapy, Karolinska Institutet, Huddinge, Sweden, 2Institute for Aging Research, Hebrew SeniorLife, Harvard Medical School & Beth Israel Deaconess Medical Center, Boston, MA

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Aerobic, Fatigue, muscle strength and physical activity

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 10, 2015

Title: Epidemiology and Public Health Poster (ARHP)

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:

Fatigue is a prominent problem in persons with rheumatoid arthritis (RA) and often has a detrimental effect on quality of life. Besides variables directly related to disease and disease impact, exercise and physical performance have been found to explain variation in fatigue. However, previous studies have used small samples and the role of aerobic capacity is unclear. The present study assessed the contribution of physical performance in the variation of fatigue in RA, beyond that of previously known factors related to disease and disease impact.

Methods:

This cross-sectional study used data from the Swedish Rheumatology Quality Registers and included 269 persons recruited for a physical activity intervention. They were all diagnosed with RA according to the ACR classification criteria, 82% women, mean age 60 ± 9 years, mean DAS28 2.8 ± 1.2, and mean HAQ 0.5 ± 0.5. The participants completed a questionnaire on fatigue, activity limitation, perceived health, pain, anxiety/depression and physical activity, and were tested for physical performance; lower limb function by Timed-stands Test, grip strength by Grippit, and aerobic capacity by Åstrand’s submaximal bicycle test. Fatigue was rated on a visual analogue scale 0-100 with severe fatigue defined as 50-100. Variation in fatigue was analyzed in two logistic regression models including A) variables related to disease and disease impact, and B) variables related to disease, disease impact and physical performance. Multiple imputation was used to account for missing data in explanatory variables. Nagelkerke’s R2 was calculated to assess model fit.

Results:

Severe fatigue was reported by 95 persons (35%). Significant univariate associations (p < 0.1) between severe fatigue and disease duration, medication with biological drugs, comorbidities, activity limitation, perceived health, pain, anxiety/depression and grip strength were found and those variables were included in the adjusted models. Model fit statistics indicated that model B explained more of the variance in severe fatigue than did model A. (Nagelkerke’s R2 0.60 and 0.67 respectively, p <.0001). Perceived health, pain and anxiety/depression contributed significantly (p< 0.05) in both models and lower limb function in model B (Table 1).

Conclusion:

The results indicate that perceived disease impact variables together with lower limb function are predictors of fatigue in persons moderately affected by RA.  The role of physical performance should be explored further with multidimensional assessments of fatigue in samples with larger variation in fatigue and in potential explanatory factors.

Table 1. Outcome of logistic regression for severe fatigue with odds ratios (OR) and 95% confidence intervals (CI) using multiple imputation to account for missing data.  Model A includes disease-related and perceived disease impact variables and Model B also includes physical performance variables (n = 269). 

 Model A

OR (95% CI)

p-value

Model B

OR (95% CI)

p-value

Disease duration

0.97 (0.93, 1.01)

0.171

Disease duration

0.97 (0.93, 1.02)

0.271

Biological drugs

0.82 (0.36, 1.88)

0.642

Biological drugs

0.86 (0.36, 2.03)

0.724

Comorbidities

1.74 (0.81, 3.71)

0.154

Comorbidities

2.10 (0.94, 4.71)

0.071

Activity limitation

1.29 (0.53, 3.15)

0.576

Activity limitation

2.26 (0.83, 6.12)

0.109

Health

1.07 (1.04, 1.11)

<0.0001

Health

1.08 (1.04, 1.12)

0.0001

Pain

1.04 (1.01, 1.07)

0.003

Pain

1.04 (1.01, 1.07)

0.005

Anxiety/depression

2.40 (1.19, 4.87)

0.015

Anxiety/depression

2.56 (1.24, 5.27)

0.011

 

 

 

Grip strength

1.00 (1.00, 1.01)

0.192

 

 

 

Lower limb function

0.95 (0.90, 1.00)

0.047

 

 

 

Aerobic capacity

1.01 (0.95, 1.07)

0.768


Disclosure: I. Demmelmaier, None; S. Pettersson, None; B. Nordgren, None; A. B. Dufour, None; C. H. Opava, None.

To cite this abstract in AMA style:

Demmelmaier I, Pettersson S, Nordgren B, Dufour AB, Opava CH. Physical Performance Contributes Only Marginally in Explaining Fatigue Variation in Persons with RA Moderately Affected By Their Disease [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/physical-performance-contributes-only-marginally-in-explaining-fatigue-variation-in-persons-with-ra-moderately-affected-by-their-disease/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/physical-performance-contributes-only-marginally-in-explaining-fatigue-variation-in-persons-with-ra-moderately-affected-by-their-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology